Business ❯ Healthcare Industry

Pharmaceutical Companies

Novo Nordisk Drug Development Eli Lilly Drug Pricing Pricing Strategies Drug Pricing Strategies Drug Pricing Agreements Drug Supply Chain Partnerships Market Competition

Roche Starts Placebo-Controlled Phase 3 Trial of Elevidys to Pursue EU Approval

The study answers an EMA call for stronger, placebo-controlled evidence after a negative review.

AMA Assigns PLA CPT Code 0640U to Plus Therapeutics’ CNSide CSF Tumor Cell Test

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

Analyses Find Limited Savings as TrumpRx Reaches 54 Drugs

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

TrumpRx Debuts With 43 Discounted Brand Drugs as Analyses Flag Cheaper Generics and Limits

TrumpRx Launches, Offering Discounted Brand‑Name Drugs Through U.S. Portal

White House Launches TrumpRx.gov, a Portal for Discounted Prescription Drugs

Dr. Oz's CNN Appearance Criticized After 'Gazelle' Remark, On‑Air High‑Five

Japan Launches Nationwide OTC Sales of NorLevo Morning-After Pill

Regeneron Beats Q4 and Charts 2026 Catalysts With FDA Decisions and Phase III Push

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

White House Unveils 'Great Healthcare Plan' With Sparse Details, Big Budget Questions

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

Mexico Pays Nearly 15 Billion Pesos to Drugmakers, Bars Repeat Contracts for Defaulters

Novo Nordisk Presses India Expansion and Higher-Dose Push as Analyst Views Diverge

CVS to Pay $37.8 Million to Settle DOJ Insulin Billing Case

Lilly Cuts Zepbound Cash Prices on LillyDirect as GLP‑1 Price Competition Deepens

Senators Edge Toward 340B Overhaul as CBO Warns on Costs and HRSA Plans 2026 Rebate Pilot